levalbuterol (Xopenex)
Jump to navigation
Jump to search
Introduction
Tradename: Xopenex. L-enantiomer of albuterol
Indications
- prevention & treatment of bronchospasm in adults & adolescents > 12 years of age
Xopenex HFA: metered dose inhaler
Mechanism of action
- selective beta-2 adrenergic agonist
- does not work any better than albuterol[3][4]
More general terms
References
- ↑ Kaiser Permanente Northern California Regional Drug Alert
- ↑ Prescriber's Letter 14(11): 2007 Levalbuterol (Xopenex) vs Albuterol Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=231109&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 3.0 3.1 Prescriber's Letter 16(10): 2009 Levalbuterol (Xopenex) vs. Albuterol: An Update Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=251027&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 4.0 4.1 Khorfan FM et al. Effects of nebulized bronchodilator therapy on heart rate and arrhythmias in critically ill adult patients. Chest 2011 Dec; 140:1466. PMID: https://www.ncbi.nlm.nih.gov/pubmed/21960699